MarketCap
Facebook
X
TelegramQuartalsbericht 2025-Q3
hinzugefügt 03.11.2025
Land |
 Kanada |
IPO-Jahr |
2014 |
Branche |
Pharmaeinzelhändler |
Börse |
NASDAQ GLOBAL |
Anteile |
77.9 M |
Marktkapitalisierung |
$ 4.36 B |
EBITDA (LTM) |
$ -216 M |
P/E (LTM) |
-14.95 |
P/S (LTM) |
265.37 |
EPS (LTM) |
-3.86 |
Andere Aktien der Branche "Pharmaeinzelhändler"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
FSD Pharma
HUGE
|
- | 5743.5 % | $ 69.7 M | Nasdaq Capital Market | Canada |
 |
MorphoSys AG
MOR
|
- | 2.43 % | $ 254 M | Nasdaq Global Select Market |  Germany |
 |
AgeX Therapeutics
AGE
|
- | -10.17 % | $ 12.2 K | NYSE American |  USA |
 |
I-Mab
IMAB
|
- | - | $ 866 M | Nasdaq Global Select Market |  China |
 |
Midatech Pharma plc
MTP
|
- | -18.52 % | $ 27.3 M | Nasdaq Global Select Market |  Britain |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
- | - | $ 40.3 B | Nasdaq Global Select Market | USA |
 |
Biophytis SA
BPTS
|
- | -13.47 % | $ 169 M | Nasdaq Capital Market |  France |
 |
Genfit SA
GNFT
|
- | 2.54 % | $ 160 B | Nasdaq Global Select Market | France |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
- | -1.52 % | $ 24.7 M | Nasdaq Capital Market | USA |
 |
Enlivex Therapeutics Ltd.
ENLV
|
$ 0.8 | -3.59 % | $ 36.6 M | Nasdaq Capital Market |  Israel |
 |
Athira Pharma
ATHA
|
- | - | $ 269 M | Nasdaq Global Select Market | USA |
 |
Exelixis
EXEL
|
$ 46.21 | -5.11 % | $ 12.5 B | Nasdaq Global Select Market,SPB | USA |
 |
Fortress Biotech
FBIO
|
$ 2.4 | -5.88 % | $ 67 M | Nasdaq Capital Market | USA |
|
Forte Biosciences
FBRX
|
$ 26.17 | -1.32 % | $ 339 M | Nasdaq Capital Market | USA |
 |
Heron Therapeutics
HRTX
|
$ 1.24 | -5.34 % | $ 207 M | Nasdaq Global Select Market,SPB | USA |
 |
Ionis Pharmaceuticals
IONS
|
$ 76.02 | -1.08 % | $ 12.2 B | Nasdaq Global Select Market,SPB | USA |
 |
BioNTech SE
BNTX
|
$ 93.02 | -2.35 % | $ 27.2 B | Nasdaq Global Select Market | Germany |
 |
Институт стволовых клеток человека
ISKJ
|
- | - | - | MOEX |  Russia |
 |
Checkmate Pharmaceuticals
CMPI
|
- | - | $ 231 M | Nasdaq Global Market | USA |
 |
Ligand Pharmaceuticals Incorporated
LGND
|
$ 210.33 | -9.55 % | $ 3.85 B | Nasdaq Global Select Market,SPB | USA |
 |
ACADIA Pharmaceuticals
ACAD
|
$ 22.57 | 5.05 % | $ 3.74 B | Nasdaq Global Select Market,SPB | USA |
 |
Mirum Pharmaceuticals
MIRM
|
$ 102.93 | -6.5 % | $ 5.17 B | Nasdaq Global Select Market | USA |
 |
MannKind Corporation
MNKD
|
$ 3.55 | -0.28 % | $ 1.09 B | Nasdaq Global Market | USA |
 |
Advaxis
ADXS
|
- | -9.65 % | $ 45.9 M | Nasdaq Capital Market | USA |
 |
Esperion Therapeutics
ESPR
|
$ 3.14 | -0.32 % | $ 653 M | Nasdaq Global Market,SPB | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
$ 3.54 | 5.67 % | $ 5.83 M | NYSE American | Israel |
 |
Aeterna Zentaris
AEZS
|
- | 5.93 % | $ 314 M | Nasdaq Capital Market | Canada |
 |
Genprex
GNPX
|
$ 0.87 | -2.84 % | $ 811 K | Nasdaq Capital Market | USA |
 |
Matinas BioPharma Holdings
MTNB
|
$ 0.65 | -5.15 % | $ 3.56 M | NYSE American | USA |
 |
Aeglea BioTherapeutics
AGLE
|
- | - | $ 1.01 B | Nasdaq Global Market | USA |
 |
CureVac N.V.
CVAC
|
- | - | $ 867 M | Nasdaq Global Market | Germany |
 |
Applied Genetic Technologies Corporation
AGTC
|
- | - | $ 26.5 M | Nasdaq Global Select Market | USA |
 |
AIkido Pharma
AIKI
|
- | 1.93 % | $ 17.4 M | Nasdaq Capital Market | USA |
 |
Akero Therapeutics
AKRO
|
- | - | $ 3.67 B | Nasdaq Global Select Market,SPB | USA |
 |
Aptose Biosciences
APTO
|
- | -45.71 % | $ 1.2 M | Nasdaq Capital Market | Canada |
 |
Aptinyx
APTX
|
- | -39.0 % | $ 4.57 M | Nasdaq Global Select Market | USA |
 |
Akouos
AKUS
|
- | 0.23 % | $ 488 M | Nasdaq Global Select Market | USA |
 |
Albireo Pharma
ALBO
|
- | -0.23 % | $ 916 M | Nasdaq Capital Market | USA |
 |
Allakos
ALLK
|
- | - | $ 28.6 M | Nasdaq Global Select Market,SPB | USA |
 |
AlloVir
ALVR
|
- | 4.14 % | $ 49.1 M | Nasdaq Global Select Market | USA |
 |
Arcutis Biotherapeutics
ARQT
|
$ 20.66 | -14.52 % | $ 2.63 B | Nasdaq Global Select Market,SPB | USA |
 |
Allena Pharmaceuticals
ALNA
|
- | 3.16 % | $ 1.9 M | Nasdaq Global Select Market | USA |
 |
Genmab A/S
GMAB
|
$ 27.06 | -2.98 % | $ 16.7 B | Nasdaq Global Select Market |  Danmark |
 |
Ampio Pharmaceuticals
AMPE
|
- | -11.43 % | $ 502 K | NYSE American | USA |
|
Applied Molecular Transport
AMTI
|
- | - | $ 10.1 M | Nasdaq Global Select Market,SPB | USA |
 |
Alpine Immune Sciences
ALPN
|
- | - | $ 2.17 B | Nasdaq Global Market | USA |
 |
Aileron Therapeutics
ALRN
|
- | 10.36 % | $ 9.8 M | Nasdaq Global Select Market | USA |
 |
Applied Therapeutics
APLT
|
- | - | $ 8.42 M | Nasdaq Global Market,SPB | USA |
 |
Aravive
ARAV
|
- | -13.39 % | $ 1.45 M | Nasdaq Global Select Market | USA |
 |
Aridis Pharmaceuticals
ARDS
|
- | 17.91 % | $ 11.1 M | Nasdaq Capital Market | USA |